Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Università degli Studi di Brescia
Brescia, ItaliaPublikationen in Zusammenarbeit mit Forschern von Università degli Studi di Brescia (22)
2024
-
Can anticoagulation be withdrawn in APS patients after aPL negativization?
Autoimmunity Reviews, Vol. 23, Núm. 1
-
Development and external validation of the 'Global Surgical-Site Infection' (GloSSI) predictive model in adult patients undergoing gastrointestinal surgery
British Journal of Surgery, Vol. 111, Núm. 6
2023
-
An International Expert Delphi Consensus on Defining Textbook Outcome in Liver Surgery (TOLS)
Annals of Surgery, Vol. 277, Núm. 5, pp. 821-828
-
Endometrial Cancer Individualized Scoring System (ECISS): A machine learning-based prediction model of endometrial cancer prognosis
International Journal of Gynecology and Obstetrics, Vol. 161, Núm. 3, pp. 760-768
-
European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care
European Journal of Cancer, Vol. 187, pp. 105-113
-
Processed Electroencephalogram-Based Monitoring to Guide Sedation in Critically Ill Adult Patients: Recommendations from an International Expert Panel-Based Consensus
Neurocritical Care, Vol. 38, Núm. 2, pp. 296-311
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)
American Journal of Hematology, Vol. 96, Núm. 1, pp. 69-79
-
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)
Journal of Clinical Oncology, Vol. 39, Núm. 20, pp. 2304-2312
2018
-
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1470-1486
-
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1557-1566
-
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1534-1545
-
Clinical utility of FDG-PET for the clinical diagnosis in MCI
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1497-1508
-
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1509-1525
-
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1546-1556
-
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1487-1496
-
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1526-1533
2017
-
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing
Current Osteoporosis Reports, Vol. 15, Núm. 5, pp. 499-506
2015
-
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Journal of the National Cancer Institute, Vol. 107, Núm. 12
2014
-
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633